Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Glutamine to Intensive Care Patients - a Prospective, Double-Blind, Placebo-Controlled Multicenter Study in the Scandinavian Countries

NCT00922714 is registered in ClinicalTrials.gov with Scandinavian Critical Care Trials Group as lead sponsor.

NCT NCT00922714
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00922714 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Glutamine to Intensive Care Patients - a Prospective, Double-Blind, Placebo-Controlled Multicenter Study in the Scandinavian Countries
Lead sponsor
Scandinavian Critical Care Trials Group
Phase
Phase 4
Overall status
Terminated
Start date
October 31, 2003
Completion date
August 31, 2009
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

icu patients